The Vanderbilt Specialty Pharmacy Health Outcomes and Research Program was established to improve patient care through sound research while furthering innovation and insights within the field of specialty pharmacy.


We focus on the link between specialty pharmacy medications, health care delivery and patient outcomes by performing research that encompasses the complete patient journey, from evaluation through treatment. Specifically, we are committed to:
parallax background


We are uniquely positioned to produce rigorous, innovative, meaningful outcomes research. Our outcomes program leverages the expertise and experience of world-renowned physician champions within the Vanderbilt University Medical Center. We also fuel our efforts through a partnership with the Department of Biostatistics, a collaborative population health department and a cutting edge Health IT department to ensure our projects are solid and sound.



  • National Association of Specialty Pharmacy (NASP) annual conference
    • Awarded Top Poster for “Outcomes (Cost or Other)” category
      • Health-System Specialty Rx: PGY1 Residency Launch
  • AJHP “Articles with Impact”: Development of quality measures for use of self-injectable biologic therapy in inflammatory bowel disease: An integrated specialty pharmacy initiative
  • VUMC’s 39th Annual Graduate Medical Education Research Forum Visual Abstracts for Honorable Mention
    • Top 6 Finalist: Extended adherence and persistence to HIV PrEP in a multidisciplinary PrEP clinic.
    • Honorable Mentions: Clinical characteristics and three-month outcomes of patients prescribed alternate-dose self-injectable biologic therapy for the management of inflammatory bowel disease, Identifying misidentified nonadherence to specialty medications: comparing rates and reasons behind nonadherence, Assessing interventions to improve patient care conducted by pharmacists at an outpatient renal transplant clinic within a collaborative pharmacy practice agreement, and Rates, reasons, and timing for treatment discontinuation in patients prescribed denosumab


  • American College of Gastroenterology Annual Meeting, Virtual Meeting. October, 2020
    • Awarded ACG Outstanding poster presenter award
      • Alternative subcutaneous biologic dosing in inflammatory bowel disease is delayed depending on insurance approval requirements
  • National Association of Specialty Pharmacy (NASP) annual conference, Virtual Meeting. September 2020
    • Awarded Top Poster for “Specialty Pharmacy Services” category
      • Access to direct acting antiviral therapy for recipients of solid organs from hepatitis-c-viremic donors
    • Awarded Top Poster for “Adherence” category
      • Modeling rates of primary medication nonadherence with specialty oncolytic agents


  • Zitter National Patient Choice Award (2019)
  • Tennessee Society of Health System Pharmacists
    • Innovative Health-System Pharmacy Practice of the Year (2019)
  • National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo
    • First place outcomes poster
      • Development of a Collaborative Pharmacy Practice Agreement to Improve Efficiency and Management of Prescribing in a Renal Transplant Clinic (Encore Presentation)
  • Academy of Managed Care and Specialty Pharmacy Annual Meeting
    • Gold ribbon abstract winners
      • A Targeted Approach to Reducing Rates of Discontinuation and Dose Reduction in Patients Receiving Sorafenib or Regorafenib
      • Development of a Collaborative Pharmacy Practice Agreement to Improve Efficiency and Management of Prescribing in a Renal Transplant Clinic


  • American College of Gastroenterology Meeting
    • Recognized as Best of ACG 2018 IBD & Liver
      • Risk Factors for Non-Adherence to Biologic Therapy in Adult Patients with Inflammatory Bowel Disease (IBD): A Retrospective Analysis
  • Academy of Managed Care and Specialty Pharmacy Nexus Meeting
    • Silver Ribbon Abstract
      • Closing the Gap: Identifying Rates and Reasons for Nonadherence in a Specialty Population


  • National Association of Specialty Pharmacy Annual Meeting
    • Third place abstract winner
      • Assessing the Impact of High Touch Specialty Pharmacy Services in Patients Receiving Teriparatide


Want to learn more about Vanderbilt Specialty Pharmacy’s Outcomes Program? Interested in partnering with us on a current or future project? We would love to hear from you! Our contact information is below:

VSP Outcomes Research Team